Mindspace is pleased to be at the forefront of psychedelic-assisted psychotherapy solutions in Canada. Specifically, in light of Health Canada’s recently announced notice of intent to revise its Special Access Programme, should Health Canada ultimately allow for SAP applications, we expect to eventually be offering both psilocybin and MDMA for a number of indications, including depression, PTSD and anxiety.

Think psychedelic-assisted psychotherapy could be for you? Complete the form below to get started.

  • What is Psychedelic-Assisted Psychotherapy with MDMA and psilocybin?

    MDMA and psilocybin are two psychedelics that are currently being studied and in the process of being approved in Canada and the United States for the treatment of a number of indications including PTSD, depression, anxiety, and substance use disorders.

    Though they are not fully approved yet for treatment, Health Canada has recently issued a statement with the intent of revising the Special Access Programme, which allows individuals to access other regulated substances for the treatment of various health issues if other means have failed. We are in the process of collecting the information of potential candidates for applications for these treatments, should the revision to the SAP go through in early 2021.

  • What is Psychedelic-Assisted Psychotherapy?

    Psychedelic assisted-psychotherapy (PAP) is a form of psychotherapy that involves the use of psychedelic substances such as psilocybin, MDMA and ketamine for the purpose of facilitating therapeutic breakthroughs and insight.

    It is a broad term that encompasses a number of different approaches and protocols using psychedelics, and which has been practiced in the Western medical model since the 1950s. Though psychedelics like LSD showed promise as therapeutic agents in those early years, a period of prohibition starting in the 1960s and through the early 2000s significantly hindered the research and development of these modalities.

    The last decade has seen a significant body of encouraging research supporting the efficacy of PAP for a number of mental health issues, especially depression, anxiety, addiction, and PTSD. Though most psychedelics are still regulated substances, the legal and medical landscape is changing quickly, and more treatment options are starting to become available to the general public.

From the Blog